• Return to Headlines

Albany Molecular Shares Up 41.3% Since SmarTrend's Buy Recommendation (AMRI)

By David Diaz

SmarTrend identified an Uptrend for Albany Molecular (:AMRI) on April 13th, 2017 at $15.39. In approximately 19 months, Albany Molecular has returned 41.31% as of today's recent price of $21.74.

In the past 52 weeks, Albany Molecular share prices have been bracketed by a low of $21.72 and a high of $21.76 and are now at $21.74, 0% above that low price. The 200-day and 50-day moving averages have moved 0% lower and 0% lower over the past week, respectively.

Albany Molecular Research, Inc., an integrated chemistry outsourcing company, offers a variety of chemistry research and development services. The Company provides its services to pharmaceutical and biotechnology companies involved in drug discovery and development. Albany offers medicinal chemistry, chemical development, analytical chemistry services, and small-scale manufacturing.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Albany Molecular shares.

Log in and add Albany Molecular (AMRI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights :amri albany molecular

Ticker(s): AMRI